Roche-owned Chugai plans 50% capital spending boost to expand in-house production
Nikkei Asia reports that the Japanese drugmaker is scaling back outsourcing as costs rise.
TLDR
Roche-owned Chugai Pharma plans to increase capital spending by 50% to ramp up in-house production, Nikkei Asia reports. The drugmaker is scaling back outsourcing as costs rise.
Combined views
8.6K
2 Sources, first seen ago